TrialClinical pharmacokinetics2016

Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus.

Eef Hoeben et al.PubMed ↗Publisher ↗

No numbers read from the abstract.